Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97502d4958f734095827d1b20327b86f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
filingDate |
2003-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0426d8a23ef29c55efba2f62720e4423 |
publicationDate |
2003-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1344529-A1 |
titleOfInvention |
Therapeutic compositions for treating male pattern baldness |
abstract |
A therapeutic formulation for use in the treatment of malenpattern baldness includes:-n a) an ingredient which inhibits aromatase activity, i.e.nreduces the rate at which testosterone is converted to oestradiol,nand b) an ingredient which reduces the amount of testosteronenwhich is bound to the SHGB, and/or c) an ingredient which increases the level of testosterone. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013011431-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2386859-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-FI20110140-A1 |
priorityDate |
2002-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |